Skip to main content
SpringerLink
Log in

Glycemic control and treatment patterns in patients with heart failure

  • Management of Heart Failure
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Patients with diabetes mellitus are more likely to develop heart failure and cardiac dysfunction (with or without coronary artery disease), and the combination portends a poorer prognosis. Although the majority of treatment options in heart failure appear to be as effective in those with diabetes as in those without, less is known about the safety and effectiveness of different antidiabetic medications in the setting of heart failure. Nevertheless, it is well recognized that many patients with diabetes mellitus may develop subclinical structural heart disease prior to overt clinical presentations. Therefore, the potential of early detection (or screening) is very important to prevent the significant disease burden of heart failure in the diabetic population. In-depth investigations of the role of current and emerging strategies of metabolic modulation are promising, although the precise therapeutic targets remain elusive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Thrainsdottir IS, Aspelund T, Thorgeirsson G., et al.:The association between glucose abnormalities and heart failure in the population-based Reykjavik study.Diabetes Care 2005,28:612–616.

    Article  PubMed  Google Scholar 

  2. Adams KF Jr, Fonarow GC, Emerman CL, et al.:Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).Am Heart J 2005,149:209–216.

    Article  PubMed  Google Scholar 

  3. Suskin N, McKelvie RS, Burns RJ, et al.:Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.Eur Heart J 2000,21:1368–1375.

    Article  PubMed  CAS  Google Scholar 

  4. Of importance From AM, Leibson CL, Bursi F, et al.:Diabetes in heart failure: prevalence and impact on outcome in the population.Am J Med 2006,119:591–599. An update from the Olmsted County outlining the increased prevalence of heart failure in patients with diabetes mellitus.

    Article  PubMed  Google Scholar 

  5. Amato I, Paolisso G, Cacciatore F, et al.:Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.Diabetes Metab 1997,23:213–218.

    PubMed  CAS  Google Scholar 

  6. Barzilay JI, Kronmal RA, Gottdiener JS, et al.: The association of fasting glucose levels with congestive heart failure in diabetic adults>or=65 years: the Cardiovascular Health Study.J Am Coll Cardiol 2004,43:2236–2241.

    Article  PubMed  CAS  Google Scholar 

  7. Ilercil A, Devereux RB, Roman MJ, et al.:Relationship of impaired glucose tolerance to left ventricular structure and function: the Strong Heart Study.Am Heart J 2001,141:992–998.

    Article  PubMed  CAS  Google Scholar 

  8. Paolisso G, Tagliamonte MR, Rizzo MR, et al.:Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.Am J Cardiol 1999,83:1338–1344.

    Article  PubMed  CAS  Google Scholar 

  9. Witteles RM, Tang WH, Jamali AH, et al.:Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.J Am Coll Cardiol 2004,44:78–81.

    Article  PubMed  CAS  Google Scholar 

  10. Iribarren C, Karter AJ, Go AS, et al.:Glycemic control and heart failure among adult patients with diabetes.Circulation 2001,103:2668–2673.

    PubMed  CAS  Google Scholar 

  11. Nichols GA, Gullion CM, Koro CE, et al.:The incidence of congestive heart failure in type 2 diabetes: an update.Diabetes Care 2004,27:1879–1884.

    Article  PubMed  Google Scholar 

  12. Kannel WB, McGee DL:Diabetes and cardiovascular disease. The Framingham study.JAMA 1979,241:2035–2038.

    Article  PubMed  CAS  Google Scholar 

  13. Bertoni AG, Hundley WG, Massing MW, et al.:Heart failure prevalence, incidence, and mortality in the elderly with diabetes.Diabetes Care 2004,27:699–703.

    Article  PubMed  Google Scholar 

  14. Vaur L, Gueret P, Lievre M, et al.:Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIA Betes, Hypertension, CArdiovascular Events and Ramipril) study.Diabetes Care 2003,26:855–860.

    Article  PubMed  Google Scholar 

  15. Of major importance Ingelsson E, Sundstrom J, Arnlov J, et al.:Insulin resistance and risk of congestive heart failure.JAMA 2005,294:334–341. Large epidemiology study relating insulin resistance to the development of heart failure.

    Article  PubMed  CAS  Google Scholar 

  16. Li C, Ford ES, McGuire LC, Mokdad AH:Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey.J Epidemiol Community Health 2007,61:67–73.

    Article  PubMed  Google Scholar 

  17. Hamby RI, Zoneraich S, Sherman L:Diahetic cardiomyopathy.JAMA 1974,229:1749–1754.

    Article  PubMed  CAS  Google Scholar 

  18. Fang ZY, Prins JB, Marwick TH:Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.Endocr Rev 2004,25:543–567.

    Article  PubMed  CAS  Google Scholar 

  19. Fonarow GC, Srikanthan P:Diabetic cardiomyopathy.Endocrinol Metab Clin North Am 2006,35:575–599, ix.

    Article  PubMed  CAS  Google Scholar 

  20. Fang ZY, Yuda S, Anderson V, et al.:Echocardiographic detection of early diabetic myocardial disease.J. Am Coll Cardiol 2003,41:611–617.

    Article  PubMed  CAS  Google Scholar 

  21. Moir S, Hanekom L, Fang ZY, et al.:Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging.Heart 2006,92:1414–1419.

    Article  PubMed  CAS  Google Scholar 

  22. Stratton IM, Adler AI, Neil HA, et al.:Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ 2000,321:405–412.

    Article  PubMed  CAS  Google Scholar 

  23. Tang WH, Jain A, Miller H, et al.:Glytemic control and treatment patterns in patients with heart failure [abstract].Eur Heart J 2005,26 (Suppl):441.

    Google Scholar 

  24. Ware MG, Flavell CM, Lewis EF, et al.:Heart failure and diabetes: collateral henefit of chronic discase management.Congest Heart Fail 2006,12:132–136.

    Article  PubMed  Google Scholar 

  25. Barsheshet A, Garty M, Grossman E, et al.:Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure.Arch Intern Med 2006,166:1613–1619.

    Article  PubMed  Google Scholar 

  26. Newton JD, Squire IB:Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure.Heart 2006,92:1441–1446.

    Article  PubMed  CAS  Google Scholar 

  27. Tang WH:Glycemic control and treatment pattern in patients with heart failure.Heart Fail Monit 2006,5:10–14.

    PubMed  CAS  Google Scholar 

  28. Eurich DT, Majumdar SR, McAlister FA, et al.:Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.Diabetes Care 2005,28:2345–2351.

    Article  PubMed  CAS  Google Scholar 

  29. Masoudi FA, Inzucchi SE, Wang Y, et al.:Thiazolidineditiones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.Circulation 2005,111:583–590.

    Article  PubMed  CAS  Google Scholar 

  30. Malmberg K, Ryden L, Efendic S, et al.:Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.J Am Coll Cardiol 1995,26:57–65.

    Article  PubMed  CAS  Google Scholar 

  31. Nichols GA, Koro CE, Gullion CM, et al.:The incidence of congestive heart failure associated with antidiabetic therapies.Diabetes Metab Res Rev 2005,21:51–57.

    Article  PubMed  CAS  Google Scholar 

  32. Tang WH:Do thiazolidinediones cause heart failure: A critical review.Cleve Clin J Med 2006,73:390–397.

    Article  PubMed  Google Scholar 

  33. Tang WH, Francis GS, Hoogwerf BJ, Young JB:Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.J Am Coll Cardiol 2003,41:1394–1398.

    Article  PubMed  CAS  Google Scholar 

  34. Thrainsdottir I, Malmberg K, Olsson A, et al.:Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure.Diab Vasc Dis Res 2004,1:40–43.

    Article  PubMed  Google Scholar 

  35. Nikolaidis LA, Mankad S, Sokos GG, et al.:Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.Circulation 2004,109:962–965.

    Article  PubMed  CAS  Google Scholar 

  36. Sokos GG, Nikolaidis LA, Mankad S, et al.:Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.J Card Fail 2006,12:694–699.

    Article  PubMed  CAS  Google Scholar 

  37. Dries DL, Sweitzer NK, Drazner MH, et al.:Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.J Am Coll Cardiol 2001,38:421–428.

    Article  PubMed  CAS  Google Scholar 

  38. Yusuf S, Ostergren JB, Gerstein HC, et al.:Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.Circulation 2005,112:48–53.

    Article  PubMed  CAS  Google Scholar 

  39. Bell DS, Lukas MA, Holdbrook FK, Fowler MB:The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.Curr Med Res Opin. 2006,22:287–296.

    Article  PubMed  CAS  Google Scholar 

  40. Deedwania PC, Giles TD, Klibaner M, et al.:Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.Am Heart J 2005,149:159–167.

    Article  PubMed  CAS  Google Scholar 

  41. Pitt B, Zannad F, Remme WJ, et al.:The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.N Engl J Med 1999,341:709–717.

    Article  PubMed  CAS  Google Scholar 

  42. Baker DW, Bahler RC, Finkelhor RS, Lauer MS:Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure.Am Heart J 2003,146:736–740.

    Article  PubMed  Google Scholar 

  43. Mueller C, Laule-Kilian K, Christ A, Perruchoud AP:The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea.Diabetologia 2006,49:629–636.

    Article  PubMed  CAS  Google Scholar 

  44. Wu AH, Omland T, Duc P, et al.:The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study.Diabetes Care 2004,27:2398–2404.

    Article  PubMed  CAS  Google Scholar 

  45. Fang ZY, Schull-Meade R, Leano R, et al.:Screening for heart disease in diabetic subjects.Am Heart J 2005,149:349–354.

    Article  PubMed  Google Scholar 

  46. Valle R, Bagolin E, Canali C, et al.:The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.Eur J Echocardiogr 2006,7:40–44.

    Article  PubMed  CAS  Google Scholar 

  47. Bhalla MA, Chiang A, Epshteyn VA, et al.:Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.J Am Coll Cardiol 2004,44:1047–52.

    Article  PubMed  CAS  Google Scholar 

  48. Opie LH:The metabolic vicious cycle in heart failure.Lancet 2004,364:1733–1734.

    Article  PubMed  Google Scholar 

  49. Of importance Eshaghian S, Horwich TB, Fonarow GC:An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.Am Heart J 2006,151:91. A very controversial paper challenging the conventional wisdom of glycemic control in the advanced heart failure population.

    Article  PubMed  CAS  Google Scholar 

  50. Smooke S, Horwich TB, Fonarow GC:Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.Am Heart J 2005,149:168–174.

    Article  PubMed  CAS  Google Scholar 

  51. Okere IC, Chess DJ, McElfresh TA, et al.:High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat.Clin Exp Pharmacol Physiol 2005,32:825–831.

    Article  PubMed  CAS  Google Scholar 

  52. Rennison JH, McElfresh TA, Okere I, et al.: High fat diet post infarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction.Am J Physiol Heart Circ Physiol 2007, Epub ahead of print. Available at http://ajpheart.physiology.org/cgi/reprint/01021.2006v1. Accessed on March 2, 2007.

  53. Tuunanen H, Engblom E, Naum A, et al.:Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure.Circulation 2006,114:2130–2137.

    Article  PubMed  CAS  Google Scholar 

  54. Cooper GJ, Chan YK, Dissanayake AM, et al.:Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals.Diabetes 2005,54:1468–1476.

    Article  PubMed  CAS  Google Scholar 

  55. Cooper GJ, Phillips AR, Choong SY, et al.:Regeneration of the heart in diabetes by selective copper chelation.Diabetes 2004,53:2501–2508.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Section of Heart Failure and Cardiac Transplantation Medicine, 9500 Euclid Avenue, Desk F25, 44195, Cleveland, OH, USA

    W. H. Wilson Tang MD

Authors
  1. W. H. Wilson Tang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. H. Wilson Tang MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson Tang, W.H. Glycemic control and treatment patterns in patients with heart failure. Curr Cardiol Rep 9, 242–247 (2007). https://doi.org/10.1007/BF02938357

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02938357

Keywords

Search

Navigation